# The New York Times Company (NYT) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Communication Services / Diversified Telecommunication Services. Price $67.28, market value $10.9 billion.

## Valuation
- **P/E (trailing): 28.0×** (5-yr avg 32.0×, 3-yr avg 31.9×). The New York Times Company trades at 28.0× trailing earnings, close to its own five-year average of 32.0×. The Communication Services median in the September 2026 study was 21.1×. Forward P/E is 21.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.19**. A PEG of 1.19 is in the range usually read as fairly priced for its growth.
- **Price / sales: 3.6×**. Each dollar of revenue is priced at 3.6×.
- **Price / book: 5.3×**. The shares trade at 5.3× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 19.4×**. Enterprise value is 19.4× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 5.7%** (5-yr avg 3.8%). Free cash flow equals 5.7% of the market value, above its five-year average of 3.8%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 3.6%**. The inverse of the P/E: 3.6% of the price is earned each year.

## Profitability
- **Operating margin: 16.0%**. 16.0% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 12.2%**. 12.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 16.9%**. 16.9% on shareholders' equity is solid.
- **Return on invested capital: 18.5%**. Return on all capital, debt included, is 18.5%: comfortably above what that capital costs.
- **Return on assets: 13.1%**. Each dollar of assets produces 13.1% of profit.

## Growth
- **Revenue growth (1 yr): 9.2%** (3-yr 7.0%/yr, 5-yr 9.6%/yr). Revenue grew 9.2% over the last year, against 9.6% a year compounded over five years.
- **EPS growth (1 yr): 18.1%** (3-yr 26.2%/yr, 5-yr 28.4%/yr). Earnings per share rose 18.1%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 69.2%/yr**. Free cash flow has compounded at 69.2% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.12**. Debt is 0.12 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. The New York Times Company holds more cash than debt.
- **Current ratio: 1.54** (quick 1.54). Current assets cover the next year's liabilities 1.54 times.
- **Piotroski F-score: 8/9**. 8 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 1.37%** ($0.82 per share, trailing). The New York Times Company yields 1.37%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 32%** (20% of free cash flow). 32% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 13**. 13 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 23.8%/yr** (1-yr 34.0%). The dividend has compounded at 23.8% a year over five years, doubling roughly every 3 years at that pace.

## Analyst view
- **Analyst consensus: buy** (9 analysts). 9 analysts cover The New York Times Company; the consensus is buy, with an average price target of $77.67 (+15% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 15.0%** (YTD -2.3%, 3-mo -12.2%). The shares are up 15.0% over twelve months including dividends.
- **From 52-week high: -22.8%** (24.4% above the low). Trading 23% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 46**. An RSI of 46 is neutral.
- **Beta (1 yr): 0.18** (volatility 29%). Beta of 0.18 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=NYT · Page: https://foliofundamentals.com/stocks/nyt

Not investment advice.